Glen Tullman, the former Allscripts CEO who left the company at the end of 2012 by mutual agreement, is back in the health field. His newest venture, Livongo, launched from the stage of TechCrunch's Disrupt conference in San Francisco and has already raised a $10 million funding round from General Catalyst Partners.
"Our plan is to use the experience gained in Silicon Valley on consumer ...